Mariusz L Hartman

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

International journal of molecular sciences

Apoptosis : an international journal on programmed cell death

Cancers

Cell death and differentiation

Medical University of Lodz (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Medical University of Lodz Oct 01 2011 - Oct 21 2015

Poland

PHD :: Department of Molecular Biology of Cancer

University of Lodz Oct 01 2006 - Jun 21 2011

Poland

MSC

Publications

Paulina Koziej, Katarzyna Kluszczyńska, Mariusz L Hartman, Małgorzata Czyż
Trametinib-Resistant Melanoma Cells Displaying MITF high /NGFR low /IL-8 low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge. International journal of molecular sciences 24 (9) (2023)
Mariusz L Hartman, Małgorzata Czyż
BCL-G: 20 years of research on a non-typical protein from the BCL-2 family. Cell death and differentiation (2023)
Paulina Koziej, Katarzyna Kluszczyńska, Mariusz L Hartman, Małgorzata Czyż
Trametinib-Resistant Melanoma Cells Displaying MITF high /NGFR low /IL-8 low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge. International journal of molecular sciences 24 (9) (2023)
Mariusz L Hartman, Paulina Koziej, Katarzyna Kluszczyńska, Małgorzata Czyż
Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal. Cancers 15 (19) (2023)
Mariusz L Hartman, Małgorzata Czyż
BCL-w: apoptotic and non-apoptotic role in health and disease. Cell death & disease 11 (4) (2020)
Mariusz L Hartman
Non-Apoptotic Cell Death Signaling Pathways in Melanoma. International journal of molecular sciences 21 (8) (2020)
Mariusz L Hartman, Magdalena Rogut, Aleksandra Mielczarek-Lewandowska, Michal Wozniak, Małgorzata Czyż
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines. International journal of molecular sciences 21 (11) (2020)
Mariusz L Hartman, Malgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Małgorzata Czyż
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity. Cells 9 (1) (2020)
Aleksandra Mielczarek-Lewandowska, Mariusz L Hartman, Małgorzata Czyż
Inhibitors of HSP90 in melanoma. Apoptosis : an international journal on programmed cell death 25 (1-2) (2020)
Aleksandra Mielczarek-Lewandowska, Malgorzata Sztiller-Sikorska, Marta Osrodek, Małgorzata Czyż, Mariusz L Hartman
17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAFV600E inhibitors in melanoma cells of different genetic subtypes. Apoptosis : an international journal on programmed cell death 24 (7-8) (2020)
Marta Osrodek, Mariusz L Hartman, Małgorzata Czyż
Physiologically Relevant Oxygen Concentration (6% O2) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro. International journal of molecular sciences 20 (17) (2019)

Mariusz L Hartman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mariusz L Hartman